BIO-RAD LABORATORIES, INC. (BIO)

387.70 -0.57% (-2.24)

Over 5Y: -51.4%

2026-08-28
200 400 600 800
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 747M Q3 '21 — Operating Cash Flow: 230.4M Q3 '21 — Free Cash Flow: 195.7M Q3 '21 — Net Income: 3.9B Q4 '21 — Revenue: 732.7M Q4 '21 — Operating Cash Flow: 170.9M Q4 '21 — Free Cash Flow: 114.7M Q4 '21 — Net Income: -1.6B Q1 '22 — Revenue: 700.1M Q1 '22 — Operating Cash Flow: 50.5M Q1 '22 — Free Cash Flow: 17.4M Q1 '22 — Net Income: -3.4B Q2 '22 — Revenue: 691.1M Q2 '22 — Operating Cash Flow: 53.3M Q2 '22 — Free Cash Flow: 35.9M Q2 '22 — Net Income: -925.1M Q3 '22 — Revenue: 680.8M Q3 '22 — Operating Cash Flow: 11M Q3 '22 — Free Cash Flow: -16.5M Q3 '22 — Net Income: -162.8M Q4 '22 — Revenue: 730.2M Q4 '22 — Operating Cash Flow: 79.6M Q4 '22 — Free Cash Flow: 44.8M Q4 '22 — Net Income: 827.7M Q1 '23 — Revenue: 676.8M Q1 '23 — Operating Cash Flow: 98.1M Q1 '23 — Free Cash Flow: 62.4M Q1 '23 — Net Income: 69M Q2 '23 — Revenue: 681.1M Q2 '23 — Operating Cash Flow: 98.1M Q2 '23 — Free Cash Flow: 63.4M Q2 '23 — Net Income: -1.2B Q3 '23 — Revenue: 632.1M Q3 '23 — Operating Cash Flow: 97.7M Q3 '23 — Free Cash Flow: 53.6M Q3 '23 — Net Income: 106.3M Q4 '23 — Revenue: 681.1M Q4 '23 — Operating Cash Flow: 81M Q4 '23 — Free Cash Flow: 38.7M Q4 '23 — Net Income: 349.7M Q1 '24 — Revenue: 610.8M Q1 '24 — Operating Cash Flow: 69.8M Q1 '24 — Free Cash Flow: 29.6M Q1 '24 — Net Income: 383.9M Q2 '24 — Revenue: 638.5M Q2 '24 — Operating Cash Flow: 97.6M Q2 '24 — Free Cash Flow: 55.3M Q2 '24 — Net Income: -2.2B Q3 '24 — Revenue: 649.7M Q3 '24 — Operating Cash Flow: 163.6M Q3 '24 — Free Cash Flow: 123.4M Q3 '24 — Net Income: 653.2M Q4 '24 — Revenue: 667.5M Q4 '24 — Operating Cash Flow: 124.2M Q4 '24 — Free Cash Flow: 81.3M Q4 '24 — Net Income: -715.8M Q1 '25 — Revenue: 585.4M Q1 '25 — Operating Cash Flow: 129.9M Q1 '25 — Free Cash Flow: 95.5M Q1 '25 — Net Income: 64M Q2 '25 — Revenue: 651.6M Q2 '25 — Operating Cash Flow: 116.5M Q2 '25 — Free Cash Flow: 70.8M Q2 '25 — Net Income: 317.8M Q3 '25 — Revenue: 653M Q3 '25 — Operating Cash Flow: 120.9M Q3 '25 — Free Cash Flow: 89.2M Q3 '25 — Net Income: -341.9M Q4 '25 — Revenue: 693.2M Q4 '25 — Operating Cash Flow: 164.9M Q4 '25 — Free Cash Flow: 119.1M Q4 '25 — Net Income: 720M Q1 '26 — Revenue: 592.1M Q1 '26 — Operating Cash Flow: 108.1M Q1 '26 — Free Cash Flow: 78.1M Q1 '26 — Net Income: -527.1M Q2 '26 — Revenue: 651M Q2 '26 — Operating Cash Flow: 98.7M Q2 '26 — Free Cash Flow: 66.7M Q2 '26 — Net Income: 371.4M -3B -1.5B 0 1.5B 3B 4.5B
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.4
OE margin 11.3%
ROIC 0.55%
Accruals -2.6%
OCF / EBIT 10.4×
FCF margin 13.6%
Gross margin 51.9%
OCF margin 19.0%
ROA 2.2%
ROE 3.1%
ROCE 0.51%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 0.02×
Segment HHI 0.52 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.7
ND/EBITDA —
Cash / Debt 1.3×
Debt / Eq 0.17×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 2.3×
F-score 5.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.2
Sales/sh Y/Y +4.8%
EPS Y/Y -27.9%
EBIT CAGR -48.6%
EBIT Y/Y -82.5%
EPS CAGR 4Y -33.3%
Sales Q/Q -0.092%
Div. growth —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.